How many treatments of spravato are needed for depression?

How many Spravato treatments are typically needed to start seeing improvement

Most patients begin with two treatments per week for the first four weeks. After that, the schedule often drops to once weekly or every other week, depending on how symptoms respond. Early studies showed measurable mood gains within the first two to four weeks when this twice-weekly schedule was followed.

What determines how long a person stays on Spravato

Clinicians adjust frequency based on depression scores and side-effect tolerance. If improvement plateaus or side effects become problematic, doctors may lengthen the interval between doses or pause treatment. Long-term data indicate that many patients continue monthly maintenance doses for six months or longer to keep gains stable.

Can fewer treatments work for some people

A small subset of patients reach remission after only four to six sessions. In these cases, clinicians still recommend a gradual taper rather than abrupt stopping to reduce relapse risk. Trial records show that stopping too early often leads to return of symptoms within weeks.

How does Spravato compare with standard antidepressants in speed

Spravato can produce noticeable effects within hours to days, whereas most oral antidepressants require four to six weeks. This rapid onset is why the drug is reserved for treatment-resistant cases where waiting weeks is not feasible.

When does the Spravato patent expire

The core patent covering the esketamine formulation used in Spravato is listed to expire in 2030, with some method-of-use patents extending to 2034. Generic entry before those dates would require successful patent challenges or regulatory exclusivities to lapse first.

Who manufactures Spravato

Janssen Pharmaceuticals, a Johnson & Johnson company, holds the approval and markets the drug. No authorized generics are currently available.

What are patients asking about side effects and monitoring

The most common concerns involve dissociation, blood-pressure spikes, and sedation during and shortly after each session. Because of these effects, each dose must be given in a certified clinic with at least two hours of observation. Patients frequently ask whether these side effects lessen with continued use; data show they often do after the first few treatments.

Are there cost or insurance barriers to completing the recommended course

A single Spravato treatment can exceed $600 before insurance, and many plans require prior authorization plus documented failure of at least two oral antidepressants. Out-of-pocket costs and clinic availability remain the main reasons some patients cannot finish the induction phase.

[1] https://www.drugpatentwatch.com/drug/Spravato